grant

Developing inhibitors of an essential histidine kinase in Staphylococcus aureus [ 2011 - 2013 ]

Also known as: Development of new antibiotics to treat Golden Staph infections

Funded by National Health and Medical Research Council
Managed by The University of Queensland
Managed by University of Queensland
Provided by   National Health and Medical Research Council

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1010776]

Researchers: Prof Glenn King (Principal investigator) ,  Prof Rob Capon

Brief description Staphylococcus aureus (Golden staph) has been termed a "superbug" because of its persistent ability to acquire resistance to a wide range of antibiotics. Once considered primarily a hospital-acquired pathogen, many patients are now being infected with antibiotic-resistant Golden staph outside of hospitals. The primary aim of this research program is to develop new antibiotics to treat antibiotic-resistant strains of Staphylococcus aureus and related pathogens.

Funding Amount $AUD 578,351.99

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Help

Related Organisations

Related People

Subjects
Biologically Active Molecules | Chemical Sciences | Medicinal and Biomolecular Chemistry | Staphylococcus aureus | antibiotic resistance | antibiotics | bacterial infection | drug development | drug discovery | infectious diseases | kinase inhibitors | organic chemistry | structural biology |
Identifiers
Viewed: [[ro.stat.viewed]]
Saved to MyRDA Save to MyRDA